LOGC ContextLogic Inc

$LOGC may have more synergy between US Salt + gChem than the market realizes. Four potential verticals: Cell & gene therapy: DMSO + NaCl USP Parenteral pharma formulations High-purity semiconductor chemicals Specialty agricultural formulations The bigger picture: a high-purity specialty chemicals platform.

I wanted to share some great news with $LOGC shareholders. The last time I bought ContextLogic on SoFi was January 20, so it had been a minute. I recently tried to buy more using profits from an options trade, but SoFi had removed the ability to purchase it. I called and asked why, since I had bought it there before. I mentioned that Fidelity and Moomoo still allow it, while E*TRADE charges a $5 commission that can add up. The $SOFI rep was genuinely great. He listened, submitted a ticket, and did what he could even though it was above his pay grade. I also pointed out that Webull and Robinhood had removed it too, and that shareholders deserve access. Moments later, SoFi relisted $LOGC. Sometimes all it takes is one phone call. A genuine thank you to the SoFi team for listening and helping make it happen. Be great, Allyn

$LOGC - Someone buying lots of shares. Almost 700 000 shares have been traded today. Expecting this rally to continue ot the next lvl of $20.

$LOGC Placing huge hope that US semiconductor companies and Venezuelian oil refineries in the US start using this chemical. If only one huge contract will be placed with one of the "big boy" this stock will make us good profit. Dimethyl Sulfoxide (DMSO) It can be a challenge to find solvents that are safe, yet powerful enough to dissolve difficult components and form stable formulations. As a dipolar aprotic solvent, Dimethyl Sulfoxide is recognized as being a superior solvent and has been referred to as the “super solvent.” DMSO is a highly polar and water miscible organic liquid. It is essentially odorless, has a low level of toxicity, and a relatively high boiling point. In many cases, while a superior solvent on its own, DMSO works well as a co-solvent for additional formulation needs.

$LOGC It should currently have a market cap of at least $900 million—reflecting the value of US Salt; the new GChem company is being acquired for $850 million, plus there is the value of the NOLs. In my view, it ought to be worth more than $20 right now...

$LOGC road salt prices goint to skyrocket upcoming winter season. Who would have thought managent here did a right move.

$LOGC Turnaround → compounder. Technical breakout intact; $14.5–15 next resistance, $13.8 key support. 2027 FCF: $95–105M on ~174M diluted units. Valuation: Bear $9.5–11 | Base $16–16.7 | Bull $18–19.2 | Stretch $21–23

$LOGC is flashing accumulation. 97.6K shares traded early 71% of its 136.9K average FULL-DAY volume. ~68% went through large blocks, another ~27% medium. That’s not random volume. Someone is absorbing supply fast.

$LOGC whoa what happened here. Someone fill me in. Was I totally wrong about this shitco?

$LOGC how can I get the rights offering at $9 since my broker doesn’t allow me to buy only sell ?

$LOGC: ContextLogic reported Q2 2026 revenue of $33.6M, roughly flat YoY, while net income shifted to a $6.3M loss from $4.7M of net income in Q2 2025. Adjusted EBITDA was $10.8M versus $14.0M a year earlier. The company is also pursuing an acquisition-driven strategy: after acquiring US Salt earlier this year, ContextLogic announced an $850M cash acquisition of gChem in August. LOGC closed September 25 at $14.75, up 0.55%.

$LOGC - If this weekly candle will be a pullback one with low volume like 2 weeks ago, then the next week should be push towards next Fib lvl 20-21.

$LOGC To fund the $850M gChem acquisition, ContextLogic will issue roughly 68.9 million to 72.4 million new shares/units via a $9.00 rights offering, expanding the total share count by ~68% to ~174 million units. Passive holders who do not participate will experience a ~41% proportional ownership dilution. At a $9.00 share price, the company's total true equity market cap would sit at ~$1.53B. Factoring in the combined earnings of US Salt and gChem under ContextLogic's $2.9 Billion tax shield, the deal yields ~$95M–$100M in tax-free net cash profits, placing the post-dilution projected P/E ratio at an 15.3x to 16.1. The P/E of companies similar is 16-20. So not sure why people think this is a good stock? Be ready to get fleeced when the offering happens. This only makes sense at 9-10 dollars a share.